Catalyst Wire Dossier Catalyst Wire Dossier

CHOP therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHOP therapy, covering 2023-04-25 to 2023-04-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy [Phase 2]

See pricing